Search Constraints
« Previous |
1 - 20 of 53
|
Next »
Search Results
Select an image to start the slideshow
The development of small molecule inhibitors for fibrosis drug discovery
1 of 20
Structure-guided approaches to the design of novel autotaxin inhibitors
2 of 20
The design and synthesis of small molecule bromodomain inhibitors
3 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
4 of 20
Understanding reaction mechanisms and structure/reactivity relationships in the electrophilic fluorination of enol esters
5 of 20
Increasing the saturation of BET inhibitors
6 of 20
Computational modelling of enzyme activity to speed up biocatalyst redesign
7 of 20
Iron-catalysed cross-couplings of secondary alkyl Grignard reagents
8 of 20
The application of flow chemistry to the synthesis of pharmaceutically privileged heterocycles
9 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
10 of 20
Chemoselective C-H functionalisation of aliphatic azacycles : utilisation of electrophilic iodine as a mild oxidant
11 of 20
Chan-Lam animation studies : solving the chemotype reactivity issue
12 of 20
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
13 of 20
Studies towards the synthesis and labelling of bioactive peptides
14 of 20
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
15 of 20
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
16 of 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
17 of 20
Development of lysine-targeted irreversible inhibitors of PI3Kδ
18 of 20
Targeted protein degradation as a new approach to drug discovery
19 of 20
New chemical approaches for the development of targeted protein degradation
20 of 20